Skip to main content

Table 4 Heterogeneity of PRMT1, ZEB1, RUNX1 and TWIST1 immunohistochemical expression among different tumor types

From: PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance

Histological subtype

PRMT1

ZEB1

RUNX1

TWIST1

 
 

+

+/−

+

+/−

+

+/−

+

−/+

ccRCC

24 (20.0)

49 (40.8)

47 (39.2)

4 (3.5)

32 (27.8)

79 (68.7)

12 (10.2)

58 (49.6)

47 (40.2)

51 (43.6)

63 (53.8)

3 (2.6)

pRCC I

2 (28.6)

2 (28.6)

3 (42.9)

0 (0.0)

0 (0.0)

7 (100)

0 (0.0)

2 (28.6)

5 (71.4)

4 (57.2)

3 (42.8)

0 (0.0)

pRCC II

3 (18.8)

9 (56.2)

4 (25.0)

0 (0.0)

1 (6.3)

15 (93.8)

0 (0.0)

7 (43.7)

9 (56.3)

11 (64.6)

5 (29.4)

0 (0.0)

chRCC

7 (25.0)

5 (17.9)

16 (57.1)

0 (0.0)

2 (7.4)

25 (92.6)

0 (0.0)

13 (48.2)

14 (51.8)

20 (74.1)

7 (25.9)

0 (0.0)

RO

18 (72.0)

6 (24.0)

1 (4.0)

6 (24.0)

18 (72.0)

1 (4.0)

0 (0.0)

9 (36.0)

16 (64.0)

25 (100)

0 (0.0)

0 (0.0)

CDC

3 (42.9)

2 (28.6)

2 (28.6)

0 (0.0)

3 (42.9)

4 (57.1)

0 (0.0)

3 (60.0)

2 (40.0)

5 (83.3)

1 (16.7)

0 (0.0)

MLCRN-LMP

3 (60.0)

2 (40.0)

0 (0.0)

0 (0.0)

0 (0.0)

5 (100)

1 (20.0)

3 (60.0)

1 (20.0)

3 (60.0)

2 (40.0)

0 (0.0)

P value

p < 0.001*

 

p < 0.001*

 

p = 0.183

p < 0.001*

  1. Abbreviations: PRMT1, protein arginine methyltransferase 1; ZEB1, Zinc Finger E-Box Binding Homeobox 1; RUNX1, Runt-related transcription factor 1; TWIST1, Twist Family BHLH Transcription Factor 1; ccRCC, clear cell renal cell carcinomas; pRCC I, papillary renal cell carcinoma type I; pRCC II, papillary renal cell carcinoma type I; chRCC, chromophobe renal cell carcinoma;CDC, collecting duct carcinomas-Bellini; MLCRN-LMP, multilocular cystic renal neoplasm of low malignant potential; +, homogenous positive; +/− heterogenous;-, homogenous negative
  2. *Statistically significant p-value